nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—brain cancer—ocular cancer	0.168	0.296	CtDrD
Etoposide—GSTT1—Carboplatin—ocular cancer	0.12	0.312	CbGbCtD
Etoposide—muscle cancer—ocular cancer	0.113	0.2	CtDrD
Etoposide—ABCC6—Dactinomycin—ocular cancer	0.102	0.267	CbGbCtD
Etoposide—germ cell cancer—ocular cancer	0.102	0.179	CtDrD
Etoposide—peripheral nervous system neoplasm—ocular cancer	0.094	0.165	CtDrD
Etoposide—sarcoma—ocular cancer	0.0905	0.159	CtDrD
Etoposide—GSTP1—Carboplatin—ocular cancer	0.0749	0.195	CbGbCtD
Etoposide—ABCC1—Dactinomycin—ocular cancer	0.0302	0.0788	CbGbCtD
Etoposide—ABCG2—Dactinomycin—ocular cancer	0.0202	0.0527	CbGbCtD
Etoposide—ABCC2—Carboplatin—ocular cancer	0.015	0.0392	CbGbCtD
Etoposide—ABCG2—Carboplatin—ocular cancer	0.0136	0.0354	CbGbCtD
Etoposide—ABCB1—Dactinomycin—ocular cancer	0.00729	0.019	CbGbCtD
Etoposide—Radiation recall reaction (dermatologic)—Dactinomycin—ocular cancer	0.00292	0.115	CcSEcCtD
Etoposide—Recall phenomenon—Dactinomycin—ocular cancer	0.00276	0.109	CcSEcCtD
Etoposide—Neutropenic sepsis—Dactinomycin—ocular cancer	0.00276	0.109	CcSEcCtD
Etoposide—Extravasation—Carboplatin—ocular cancer	0.00148	0.0585	CcSEcCtD
Etoposide—Phlebitis—Carboplatin—ocular cancer	0.00109	0.043	CcSEcCtD
Etoposide—Ascites—Dactinomycin—ocular cancer	0.00105	0.0417	CcSEcCtD
Etoposide—Myelosuppression—Dactinomycin—ocular cancer	0.00102	0.0404	CcSEcCtD
Etoposide—Febrile neutropenia—Dactinomycin—ocular cancer	0.000797	0.0315	CcSEcCtD
Etoposide—Hepatotoxicity—Dactinomycin—ocular cancer	0.000621	0.0245	CcSEcCtD
Etoposide—Necrosis—Dactinomycin—ocular cancer	0.000611	0.0241	CcSEcCtD
Etoposide—Extravasation—Dactinomycin—ocular cancer	0.000549	0.0217	CcSEcCtD
Etoposide—Ulcer—Dactinomycin—ocular cancer	0.000507	0.02	CcSEcCtD
Etoposide—Infection—Carboplatin—ocular cancer	0.000458	0.0181	CcSEcCtD
Etoposide—Oesophagitis—Dactinomycin—ocular cancer	0.000438	0.0173	CcSEcCtD
Etoposide—Mouth ulceration—Dactinomycin—ocular cancer	0.000433	0.0171	CcSEcCtD
Etoposide—Sepsis—Dactinomycin—ocular cancer	0.000416	0.0164	CcSEcCtD
Etoposide—Phlebitis—Dactinomycin—ocular cancer	0.000404	0.016	CcSEcCtD
Etoposide—Pain—Carboplatin—ocular cancer	0.000394	0.0156	CcSEcCtD
Etoposide—Body temperature increased—Carboplatin—ocular cancer	0.000364	0.0144	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Dactinomycin—ocular cancer	0.000313	0.0124	CcSEcCtD
Etoposide—Dysphagia—Dactinomycin—ocular cancer	0.000301	0.0119	CcSEcCtD
Etoposide—Pancytopenia—Dactinomycin—ocular cancer	0.000286	0.0113	CcSEcCtD
Etoposide—Neutropenia—Dactinomycin—ocular cancer	0.000281	0.0111	CcSEcCtD
Etoposide—Pneumonia—Dactinomycin—ocular cancer	0.00027	0.0107	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Dactinomycin—ocular cancer	0.000266	0.0105	CcSEcCtD
Etoposide—Stomatitis—Dactinomycin—ocular cancer	0.000261	0.0103	CcSEcCtD
Etoposide—Agranulocytosis—Dactinomycin—ocular cancer	0.00025	0.00989	CcSEcCtD
Etoposide—Erythema multiforme—Dactinomycin—ocular cancer	0.000228	0.00899	CcSEcCtD
Etoposide—Flushing—Dactinomycin—ocular cancer	0.000223	0.00883	CcSEcCtD
Etoposide—Chills—Dactinomycin—ocular cancer	0.000216	0.00853	CcSEcCtD
Etoposide—Alopecia—Dactinomycin—ocular cancer	0.000213	0.0084	CcSEcCtD
Etoposide—Ill-defined disorder—Dactinomycin—ocular cancer	0.000194	0.00768	CcSEcCtD
Etoposide—Anaemia—Dactinomycin—ocular cancer	0.000194	0.00765	CcSEcCtD
Etoposide—Malaise—Dactinomycin—ocular cancer	0.000189	0.00747	CcSEcCtD
Etoposide—Leukopenia—Dactinomycin—ocular cancer	0.000188	0.00741	CcSEcCtD
Etoposide—Discomfort—Dactinomycin—ocular cancer	0.000176	0.00696	CcSEcCtD
Etoposide—Infection—Dactinomycin—ocular cancer	0.00017	0.00671	CcSEcCtD
Etoposide—Thrombocytopenia—Dactinomycin—ocular cancer	0.000167	0.00662	CcSEcCtD
Etoposide—Anorexia—Dactinomycin—ocular cancer	0.000163	0.00644	CcSEcCtD
Etoposide—Decreased appetite—Dactinomycin—ocular cancer	0.000149	0.00587	CcSEcCtD
Etoposide—Fatigue—Dactinomycin—ocular cancer	0.000147	0.00583	CcSEcCtD
Etoposide—Pain—Dactinomycin—ocular cancer	0.000146	0.00578	CcSEcCtD
Etoposide—Feeling abnormal—Dactinomycin—ocular cancer	0.000141	0.00557	CcSEcCtD
Etoposide—Gastrointestinal pain—Dactinomycin—ocular cancer	0.00014	0.00553	CcSEcCtD
Etoposide—Body temperature increased—Dactinomycin—ocular cancer	0.000135	0.00534	CcSEcCtD
Etoposide—Abdominal pain—Dactinomycin—ocular cancer	0.000135	0.00534	CcSEcCtD
Etoposide—Hypersensitivity—Dactinomycin—ocular cancer	0.000126	0.00498	CcSEcCtD
Etoposide—Asthenia—Dactinomycin—ocular cancer	0.000123	0.00485	CcSEcCtD
Etoposide—Diarrhoea—Dactinomycin—ocular cancer	0.000117	0.00462	CcSEcCtD
Etoposide—Vomiting—Dactinomycin—ocular cancer	0.000109	0.0043	CcSEcCtD
Etoposide—Rash—Dactinomycin—ocular cancer	0.000108	0.00426	CcSEcCtD
Etoposide—Nausea—Dactinomycin—ocular cancer	0.000102	0.00401	CcSEcCtD
Etoposide—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ocular cancer	5.4e-05	0.00232	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—E2F3—ocular cancer	5.33e-05	0.00229	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—RBBP4—ocular cancer	5.33e-05	0.00229	CbGpPWpGaD
Etoposide—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—ocular cancer	5.23e-05	0.00224	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—CDK2—ocular cancer	5.21e-05	0.00224	CbGpPWpGaD
Etoposide—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	5.17e-05	0.00222	CbGpPWpGaD
Etoposide—TOP2A—Mitotic G1-G1/S phases—RB1—ocular cancer	5.12e-05	0.0022	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CDC25A—ocular cancer	5.07e-05	0.00218	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CCND3—ocular cancer	5.03e-05	0.00216	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TFDP1—ocular cancer	4.96e-05	0.00213	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—CDK4—ocular cancer	4.92e-05	0.00211	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	4.77e-05	0.00205	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	4.72e-05	0.00203	CbGpPWpGaD
Etoposide—ABCG2—Fluoropyrimidine Activity—TP53—ocular cancer	4.71e-05	0.00202	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	4.68e-05	0.00201	CbGpPWpGaD
Etoposide—CYP2E1—Tryptophan metabolism—MDM2—ocular cancer	4.52e-05	0.00194	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CCND3—ocular cancer	4.49e-05	0.00193	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	4.49e-05	0.00193	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	4.46e-05	0.00191	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	4.38e-05	0.00188	CbGpPWpGaD
Etoposide—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ocular cancer	4.33e-05	0.00186	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—CDK4—ocular cancer	4.28e-05	0.00184	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—RB1—ocular cancer	4.28e-05	0.00184	CbGpPWpGaD
Etoposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	4.18e-05	0.00179	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PSPH—ocular cancer	4.14e-05	0.00178	CbGpPWpGaD
Etoposide—GSTP1—NRF2 pathway—TGFB1—ocular cancer	4.09e-05	0.00175	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	4.04e-05	0.00174	CbGpPWpGaD
Etoposide—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ocular cancer	3.99e-05	0.00171	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	3.87e-05	0.00166	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—GNA11—ocular cancer	3.85e-05	0.00165	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	3.85e-05	0.00165	CbGpPWpGaD
Etoposide—TOP2A—Mitotic G1-G1/S phases—CCND1—ocular cancer	3.8e-05	0.00163	CbGpPWpGaD
Etoposide—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	3.78e-05	0.00162	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CDK6—ocular cancer	3.74e-05	0.00161	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—E2F1—ocular cancer	3.74e-05	0.0016	CbGpPWpGaD
Etoposide—TOP2A—Mitotic G1-G1/S phases—CDKN1A—ocular cancer	3.68e-05	0.00158	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—MDM2—ocular cancer	3.65e-05	0.00157	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—GNAQ—ocular cancer	3.58e-05	0.00154	CbGpPWpGaD
Etoposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ocular cancer	3.56e-05	0.00153	CbGpPWpGaD
Etoposide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ocular cancer	3.43e-05	0.00147	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PSPH—ocular cancer	3.37e-05	0.00144	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	3.35e-05	0.00144	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CDK6—ocular cancer	3.35e-05	0.00144	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—CDKN1B—ocular cancer	3.33e-05	0.00143	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	3.31e-05	0.00142	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PSPH—ocular cancer	3.25e-05	0.00139	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CDK2—ocular cancer	3.22e-05	0.00138	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CCND2—ocular cancer	3.22e-05	0.00138	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—HDAC1—ocular cancer	3.22e-05	0.00138	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	3.18e-05	0.00137	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—CDKN1A—ocular cancer	3.08e-05	0.00132	CbGpPWpGaD
Etoposide—TOP2A—Mitotic G1-G1/S phases—MYC—ocular cancer	3.05e-05	0.00131	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CDK4—ocular cancer	3.05e-05	0.00131	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	3.02e-05	0.0013	CbGpPWpGaD
Etoposide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	2.95e-05	0.00127	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—EP300—ocular cancer	2.93e-05	0.00126	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CDKN2B—ocular cancer	2.89e-05	0.00124	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	2.88e-05	0.00124	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—HDAC1—ocular cancer	2.88e-05	0.00124	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CCND2—ocular cancer	2.88e-05	0.00124	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PSPH—ocular cancer	2.86e-05	0.00123	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	2.79e-05	0.0012	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	2.77e-05	0.00119	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PSPH—ocular cancer	2.74e-05	0.00118	CbGpPWpGaD
Etoposide—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	2.72e-05	0.00117	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—CDKN1B—ocular cancer	2.71e-05	0.00116	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	2.65e-05	0.00114	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—E2F1—ocular cancer	2.65e-05	0.00114	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—RB1—ocular cancer	2.65e-05	0.00114	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	2.63e-05	0.00113	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—CCND1—ocular cancer	2.58e-05	0.00111	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CDKN2B—ocular cancer	2.58e-05	0.00111	CbGpPWpGaD
Etoposide—ABCC1—Disease—SAG—ocular cancer	2.57e-05	0.0011	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—EP300—ocular cancer	2.55e-05	0.00109	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	2.54e-05	0.00109	CbGpPWpGaD
Etoposide—ABCC3—NRF2 pathway—TGFB1—ocular cancer	2.52e-05	0.00108	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—CDKN1A—ocular cancer	2.5e-05	0.00107	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	2.48e-05	0.00106	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	2.48e-05	0.00106	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—EP300—ocular cancer	2.38e-05	0.00102	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—E2F1—ocular cancer	2.37e-05	0.00102	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	2.31e-05	0.000992	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	2.3e-05	0.000989	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	2.29e-05	0.000982	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CDK2—ocular cancer	2.28e-05	0.000981	CbGpPWpGaD
Etoposide—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	2.28e-05	0.00098	CbGpPWpGaD
Etoposide—ABCC1—Disease—E2F5—ocular cancer	2.27e-05	0.000975	CbGpPWpGaD
Etoposide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	2.26e-05	0.00097	CbGpPWpGaD
Etoposide—ABCC1—Disease—E2F4—ocular cancer	2.23e-05	0.000956	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	2.19e-05	0.000941	CbGpPWpGaD
Etoposide—ABCC1—Disease—RBL1—ocular cancer	2.18e-05	0.000937	CbGpPWpGaD
Etoposide—ABCC1—Disease—RPL39—ocular cancer	2.18e-05	0.000937	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PSPH—ocular cancer	2.18e-05	0.000935	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	2.18e-05	0.000934	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	2.18e-05	0.000934	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CDK4—ocular cancer	2.16e-05	0.000927	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—GNA11—ocular cancer	2.11e-05	0.000906	CbGpPWpGaD
Etoposide—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	2.1e-05	0.000899	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—TP53—ocular cancer	2.09e-05	0.000899	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	2.07e-05	0.000889	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—MYC—ocular cancer	2.07e-05	0.000889	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CDKN1B—ocular cancer	2.06e-05	0.000885	CbGpPWpGaD
Etoposide—UGT1A1—NRF2 pathway—TGFB1—ocular cancer	2.05e-05	0.00088	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PSPH—ocular cancer	2.05e-05	0.00088	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PSPH—ocular cancer	2.05e-05	0.000878	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CDK2—ocular cancer	2.04e-05	0.000877	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	2.04e-05	0.000877	CbGpPWpGaD
Etoposide—ABCC2—NRF2 pathway—TGFB1—ocular cancer	2e-05	0.000859	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CCND1—ocular cancer	1.97e-05	0.000844	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	1.96e-05	0.000843	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—GNAQ—ocular cancer	1.96e-05	0.000842	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CDK4—ocular cancer	1.93e-05	0.000829	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	1.9e-05	0.000814	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	1.9e-05	0.000814	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	1.89e-05	0.000812	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—RB1—ocular cancer	1.88e-05	0.000806	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—TP53—ocular cancer	1.82e-05	0.000782	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	1.8e-05	0.000773	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PSPH—ocular cancer	1.77e-05	0.000761	CbGpPWpGaD
Etoposide—ABCC1—Disease—TFDP1—ocular cancer	1.76e-05	0.000755	CbGpPWpGaD
Etoposide—PTGS2—Disease—SAG—ocular cancer	1.72e-05	0.00074	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—RB1—ocular cancer	1.68e-05	0.000721	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—HRAS—ocular cancer	1.63e-05	0.000698	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	1.6e-05	0.000688	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—MYC—ocular cancer	1.58e-05	0.000677	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TGFB1—ocular cancer	1.57e-05	0.000676	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	1.55e-05	0.000667	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PSPH—ocular cancer	1.54e-05	0.000663	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—TGFB1—ocular cancer	1.54e-05	0.00066	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	1.54e-05	0.000659	CbGpPWpGaD
Etoposide—PTGS2—Disease—E2F5—ocular cancer	1.53e-05	0.000655	CbGpPWpGaD
Etoposide—PTGS2—Disease—E2F4—ocular cancer	1.49e-05	0.000641	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	1.49e-05	0.000639	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	1.47e-05	0.00063	CbGpPWpGaD
Etoposide—PTGS2—Disease—RPL39—ocular cancer	1.47e-05	0.000629	CbGpPWpGaD
Etoposide—PTGS2—Disease—RBL1—ocular cancer	1.47e-05	0.000629	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	1.46e-05	0.000627	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—MDM2—ocular cancer	1.43e-05	0.000614	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	1.4e-05	0.000602	CbGpPWpGaD
Etoposide—ABCC1—Disease—MAML2—ocular cancer	1.4e-05	0.0006	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CCND1—ocular cancer	1.39e-05	0.000599	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	1.35e-05	0.000579	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	1.34e-05	0.000574	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CDKN1B—ocular cancer	1.31e-05	0.000561	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GNA11—ocular cancer	1.3e-05	0.00056	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TP53—ocular cancer	1.3e-05	0.000556	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	1.29e-05	0.000556	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—EP300—ocular cancer	1.29e-05	0.000552	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—EP300—ocular cancer	1.28e-05	0.000551	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CCND1—ocular cancer	1.25e-05	0.000535	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	1.23e-05	0.00053	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PSPH—ocular cancer	1.23e-05	0.000529	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	1.23e-05	0.000529	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GNAQ—ocular cancer	1.21e-05	0.00052	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CDKN1A—ocular cancer	1.21e-05	0.000518	CbGpPWpGaD
Etoposide—PTGS2—Disease—TFDP1—ocular cancer	1.18e-05	0.000507	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—EP300—ocular cancer	1.15e-05	0.000493	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—MYC—ocular cancer	1.12e-05	0.00048	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	1.09e-05	0.000467	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	1.07e-05	0.000461	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	1.07e-05	0.00046	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GNA11—ocular cancer	1.06e-05	0.000455	CbGpPWpGaD
Etoposide—ABCC1—Disease—HDAC1—ocular cancer	1.02e-05	0.000439	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GNA11—ocular cancer	1.02e-05	0.000438	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—MYC—ocular cancer	1e-05	0.000429	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	9.94e-06	0.000427	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GNAQ—ocular cancer	9.85e-06	0.000423	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—EP300—ocular cancer	9.78e-06	0.00042	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PSPH—ocular cancer	9.51e-06	0.000408	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GNAQ—ocular cancer	9.5e-06	0.000408	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	9.49e-06	0.000407	CbGpPWpGaD
Etoposide—PTGS2—Disease—MAML2—ocular cancer	9.38e-06	0.000403	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	9.18e-06	0.000394	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN2B—ocular cancer	9.16e-06	0.000393	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GNA11—ocular cancer	8.99e-06	0.000386	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	8.81e-06	0.000378	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	8.73e-06	0.000375	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GNA11—ocular cancer	8.64e-06	0.000371	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GNAQ—ocular cancer	8.36e-06	0.000359	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TP53—ocular cancer	8.21e-06	0.000353	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GNAQ—ocular cancer	8.03e-06	0.000345	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—AKT1—ocular cancer	7.78e-06	0.000334	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	7.66e-06	0.000329	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	7.61e-06	0.000327	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	7.59e-06	0.000326	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	7.44e-06	0.000319	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—EP300—ocular cancer	7.05e-06	0.000303	CbGpPWpGaD
Etoposide—PTGS2—Disease—HDAC1—ocular cancer	6.86e-06	0.000294	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GNA11—ocular cancer	6.86e-06	0.000294	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	6.48e-06	0.000278	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GNA11—ocular cancer	6.45e-06	0.000277	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GNA11—ocular cancer	6.44e-06	0.000276	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GNAQ—ocular cancer	6.37e-06	0.000274	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	6.25e-06	0.000268	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN2B—ocular cancer	6.15e-06	0.000264	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GNAQ—ocular cancer	6e-06	0.000258	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GNAQ—ocular cancer	5.99e-06	0.000257	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GNA11—ocular cancer	5.58e-06	0.000239	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	5.28e-06	0.000226	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GNAQ—ocular cancer	5.19e-06	0.000223	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	5.14e-06	0.000221	CbGpPWpGaD
Etoposide—ABCC1—Disease—MDM2—ocular cancer	5.08e-06	0.000218	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GNA11—ocular cancer	4.86e-06	0.000209	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1B—ocular cancer	4.64e-06	0.000199	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GNAQ—ocular cancer	4.52e-06	0.000194	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—EP300—ocular cancer	4.36e-06	0.000187	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1A—ocular cancer	4.28e-06	0.000184	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—ocular cancer	4.26e-06	0.000183	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	4.18e-06	0.00018	CbGpPWpGaD
Etoposide—ABCC1—Disease—EP300—ocular cancer	4.08e-06	0.000175	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GNA11—ocular cancer	3.88e-06	0.000167	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GNAQ—ocular cancer	3.61e-06	0.000155	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—ocular cancer	3.55e-06	0.000152	CbGpPWpGaD
Etoposide—ABCC1—Disease—TGFB1—ocular cancer	3.54e-06	0.000152	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—EP300—ocular cancer	3.54e-06	0.000152	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—EP300—ocular cancer	3.41e-06	0.000146	CbGpPWpGaD
Etoposide—PTGS2—Disease—MDM2—ocular cancer	3.41e-06	0.000146	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1B—ocular cancer	3.11e-06	0.000134	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—EP300—ocular cancer	3e-06	0.000129	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GNA11—ocular cancer	2.99e-06	0.000129	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	2.91e-06	0.000125	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—EP300—ocular cancer	2.89e-06	0.000124	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1A—ocular cancer	2.87e-06	0.000123	CbGpPWpGaD
Etoposide—ABCC1—Disease—HRAS—ocular cancer	2.79e-06	0.00012	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GNAQ—ocular cancer	2.78e-06	0.000119	CbGpPWpGaD
Etoposide—PTGS2—Disease—EP300—ocular cancer	2.73e-06	0.000117	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—ocular cancer	2.63e-06	0.000113	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—ocular cancer	2.46e-06	0.000106	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—ocular cancer	2.38e-06	0.000102	CbGpPWpGaD
Etoposide—PTGS2—Disease—TGFB1—ocular cancer	2.38e-06	0.000102	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—EP300—ocular cancer	2.29e-06	9.83e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—EP300—ocular cancer	2.16e-06	9.25e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—EP300—ocular cancer	2.15e-06	9.24e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—ocular cancer	2.14e-06	9.18e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—ocular cancer	2.06e-06	8.85e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HRAS—ocular cancer	1.87e-06	8.03e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—EP300—ocular cancer	1.86e-06	8e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—ocular cancer	1.81e-06	7.79e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—ocular cancer	1.74e-06	7.48e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—ocular cancer	1.65e-06	7.09e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—EP300—ocular cancer	1.62e-06	6.97e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—ocular cancer	1.38e-06	5.94e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—ocular cancer	1.3e-06	5.59e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—ocular cancer	1.3e-06	5.58e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—EP300—ocular cancer	1.3e-06	5.56e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—ocular cancer	1.13e-06	4.83e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—EP300—ocular cancer	1e-06	4.29e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—ocular cancer	9.81e-07	4.21e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—ocular cancer	7.83e-07	3.36e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—ocular cancer	6.05e-07	2.59e-05	CbGpPWpGaD
